RDA Financial Network Sells 244 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

RDA Financial Network decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 8,622 shares of the healthcare conglomerate’s stock after selling 244 shares during the period. UnitedHealth Group comprises approximately 1.6% of RDA Financial Network’s holdings, making the stock its 12th largest position. RDA Financial Network’s holdings in UnitedHealth Group were worth $5,041,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the third quarter valued at approximately $27,000. Macroview Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Delos Wealth Advisors LLC increased its holdings in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group in the second quarter valued at about $31,000. Finally, Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Price Performance

UNH stock traded down $47.59 during mid-day trading on Tuesday, hitting $557.81. 10,778,757 shares of the stock were exchanged, compared to its average volume of 3,944,671. The stock has a market capitalization of $515.09 billion, a price-to-earnings ratio of 37.34, a PEG ratio of 1.66 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The business has a fifty day moving average price of $584.39 and a 200 day moving average price of $532.15.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the prior year, the business posted $6.14 EPS. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.51%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 55.70%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on UNH shares. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th. Barclays boosted their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 1st. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price target for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Finally, HSBC raised their target price on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $617.37.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.